In vivo anti-herpes simplex virus activity of a sulfated derivative of agaricus brasiliensis mycelial polysaccharide

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2541-2549

  Cardozo, F T G S ^a   Larsen, I V ^a   Carballo, E V ^a   Jose, G ^a   Stern, R A ^a   Brummel, R C ^a   Camelini, C M ^a   Rossi, M J ^a   Simoes, C M O ^a   Brandt, C R ^a,b,c  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Department of Medical Microbiology and Immunology ^*  (Brazil)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MANNAN; MI S; MICROBICIDE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

AGARICUS BRASILIENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BLEPHARITIS; CELL SPREADING; CONTROLLED STUDY; CORNEA DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EYE DISEASE; FEMALE; FUNGAL CELL; FUNGAL GENITAL INFECTION; FUNGUS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IN VIVO STUDY; KERATITIS; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SKIN INFECTION; SULFATION; VIRUS ATTACHMENT; VIRUS ENTRY;

AGARICUS; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; FEMALE; FUNGAL POLYSACCHARIDES; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; SULFATES; TREATMENT OUTCOME; VERO CELLS;

EID: 84877846370     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02250-12     Document Type: Article

References (41)

1. Roizman B, Knipe DM, Whitley RJ. 2007. Herpes simplex viruses, p 2502-2601. In Knipe DM, Howley PM, Griffin D, Lamb R, Martin M, Roizman B, and Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Liesegang TJ. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13.
3. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964-973.
4. Clemens SAC, Farhat CK. 2010. Seroprevalence of herpes simplex 1-2 antibodies in Brazil. Rev. Saude Publica 44:726-734.
5. Cowan FM, French RS, Mayaud P, Gopal R, Robinson NJ, Artimos De Oliveira S, Faillace T, Uusküla A, Nygard-Kibur M, Ramalingam S, Sridharan G, El Aouad R, Alami K, Rbai M, Sunil-Chandra NP, Brown DW. 2003. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex. Transm. Infect. 79:286-290.
6. Fatahzadeh M, Schwartz RA. 2007. Human Herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. J. Am. Acad. Dermatol. 57:737-763.
7. Gupta R, Warren T, Wald A. 2007. Genital herpes. Lancet 370:2127-2137.
8. Van de Perre P, Segondy M, Foulongne V, Ouedraogo A, Konate I, Huraux J-M, Mayaud P, Nagot N. 2008. Herpes simplex virus and HIV-1: Deciphering viral synergy. Lancet Infect. Dis. 8:490-497.
9. Piret J, Boivin G. 2011. Resistance of herpes simplex viruses to nucleoside analogues: Mechanisms, prevalence, and management. Antimicrob. Agents Chemother. 55:459-472.
10. Buckheit RW, Jr, Watson KM, Morrow KM, Ham AS. 2010. Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res. 85:142-158.
11. Obiero J, Mwethera PG, Wiysonge CS. 2012. Topical microbicides for prevention of sexually transmitted infections. Cochrane Database Syst. Rev. 6:CD007961. doi:10.1002/14651858.CD007961.pub2.
12. Van Damme L, Szpir M. 2012. Current status of topical antiretroviral chemoprophylaxis. Curr. Opin. HIV AIDS 7:520-525.
13. Mertenskoetter T, Kaptur PE. 2011. Update on microbicide research and development-seeking new HIV prevention tools for women. Eur. J. Med. Res. 16:1-6.
14. Abdool Karim SS, Baxter C. 2012. Overview of microbicides for the prevention of human immunodeficiency virus. Best Pract. Res. Clin. Obst. Gynaecol. 26:427-439.
15. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P. 2008. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. Lancet 372:1977-1987.
16. Van Damme L, Govinden R, Mirembe FM, Guédou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D. 2008. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N. Engl. J. Med. 359:463-472.
17. Cardozo FTGS, Camelini CM, Mascarello A, Rossi MJ, Nunes RJ, Barardi CR, de Mendonça MM, Simões CMO. 2011. Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia. Antiviral Res. 92:108-114.
18. Cardozo FTGS, Camelini CM, Cordeiro MNS, Mascarello A, Malagoli BG, Larsen I, Rossi MJ, Nunes RJ, Braga FC, Brandt CR, Simões CMO. 17 March 2013. Characterization and cytotoxic activity of sulfated derivatives of polysaccharides from Agaricus brasiliensis. Int. J. Biol. Macromol. [Epub ahead of print.] pii: S0141-8130(13)00112-8. doi:10.1016/j .ijbiomac.2013.03.026.
19. Grau DR, Visalli RJ, Brandt CR. 1989. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest. Ophthalmol. Vis. Sci. 30:2474-2480.
20. Berdugo M, Larsen IV, Abadie C, Deloche C, Kowalczuk L, Touchard E, Dubielzig R, Brandt CR, Behar-Cohen F, Combette JM. 2012. Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus igg fab fragment following topical application. Antimicrob. Agents Chemother. 56:1390-1402.
21. Brandt CR, Akkarawongsa R, Altmann S, Jose G, Kolb AW, Waring AJ, Lehrer RI. 2007. Evaluation of a theta-defensin in a murine model of herpes simplex virus type 1 keratitis. Invest. Ophthalmol. Vis. Sci. 48: 5118-5124.
22. Chuanasa T, Phromjai J, Lipipun V, Likhitwitayawuid K, Suzuki M, Pramyothin P, Hattori M, Shiraki K. 2008. Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: Mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice. Antiviral Res. 80:62-70.
23. Brandt CR, Spencer B, Imesch P, Garneau M, Deziel R. 1996. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease. Antimicrob. Agents Chemother. 40:1078-1084.
24. Park HJ, Kurokawa M, Shiraki K, Nakamura N, Choi JS, Hattori M. 2005. Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice. Biol. Pharm. Bull. 28:2258-2262.
25. Bernstein DI, Goyette N, Cardin R, Kern ER, Boivin G, Ireland J, Juteau JM, Vaillant A. 2008. Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo. Antimicrob. Agents Chemother. 52:2727-2733.
26. Gill N, Rosenthal KL, Ashkar AA. 2005. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J. Virol. 79:4470-4478.
27. Green RH, Woolley DW. 1947. Inhibition by certain polysaccharides of hemagglutination and of multiplication of influenza virus. J. Exp. Med. 86:55-64.
28. Ohta Y, Lee JB, Hayashi K, Hayashi T. 2009. Isolation of sulfated galactan from Codium fragile and its antiviral effect. Biol. Pharm. Bull. 32:892-898.
29. Piret J, Lamontagne J, Bestman-Smith J, Roy S, Gourde P, Désormeaux A, Omar RF, Juhász J, Bergeron MG. 2000. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J. Clin. Microbiol. 38:110-119.
30. Huheihel M, Ishanu V, Tal J, Arad S. 2002. Activity of Porphyridium sp. polysaccharide against herpes simplex viruses in vitro and in vivo. J. Biochem. Biophys. Methods 50:189-200.
31. Cooper R, Dragar C, Elliot K, Fitton JH, Godwin J, Thompson K. 2002. GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes. BMC Complement. Altern. Med. 2:11. doi:10.1186/1472-6882-2-11.
32. Carlucci MJ, Scolaro LA, Noseda MD, Cerezo AS, Damonte EB. 2004. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antiviral Res. 64:137-141.
33. Baba M, Snoeck R, Pauwels R, De Clercq E. 1988. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Chemother. 32: 1742-1745.
34. Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T. 2008. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int. Immunopharmacol. 8:109-116.
35. Herold BC, Siston A, Bremer J, Kirkpatrick R, Wilbanks G, Fugedi P, Peto C, Cooper M. 1997. Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob. Agents Chemother. 41:2776-2780.
36. Liang E, Kabcenell AK, Coleman JR, Robson J, Ruffles R, Yazdanian M. 2001. Permeability measurement of macromolecules and assessment of mucosal antigen sampling using in vitro convertedMcells. J. Pharmacol. Toxicol. Methods 46:93-101.
37. Dawes J, Hodson BA, Pepper DS. 1989. The absorption, clearance and metabolic fate of dermatan sulphate administered to man-studies using a radioiodinated derivative. Thromb. Haemostasis 62:945-949.
38. Volpi N, Cusmano M, Venturelli T. 1995. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma. Biochim. Biophys. Acta 1243:49-58.
39. Yang T, Jia M, Zhou S, Pan F, Mei Q. 2012. Antivirus and immune enhancement activities of sulfated polysaccharide from Angelica sinensis. Int. J. Biol. Macromol. 50:768-772.
40. Brandt CR, Piraino F. 2000. Mushroom antivirals. Recent Res. Dev. Antimicrob. Agents Chemother. 4:11-26.
41. Zeitlin L, Whaley KJ, Hegarty TA, Moench TR, Cone RA. 1997. Tests of vaginal microbicides in the mouse genital herpes model. Contraception 56:329-335.